Aliada Therapeutics
Biotechnology, Boston, Massachusetts, United States, 11-50 Employees
Phone Number: +17*********
Who is ALIADA THERAPEUTICS
Biologics are transforming the treatment of numerous diseases, but many CNS diseases remain largely out of reach due to the challenge of crossing the blood-brain barrier and navigating th...
Read More
-
Headquarters: Boston, Massachusetts, United States
-
Date Founded: 2021
-
Employees: 11-50
-
Revenue: $1 Billion and Over
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 561110 |
Show More
Does something look wrong? Fix it. | View contact records from ALIADA THERAPEUTICS
Aliada Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Aliada Therapeutics
Answer: Aliada Therapeutics's headquarters are located at Boston, Massachusetts, United States
Answer: Aliada Therapeutics's phone number is +17*********
Answer: Aliada Therapeutics's official website is https://aliadatx.com
Answer: Aliada Therapeutics's revenue is $1 Billion and Over
Answer: Aliada Therapeutics's SIC: 2834
Answer: Aliada Therapeutics's NAICS: 561110
Answer: Aliada Therapeutics has 11-50 employees
Answer: Aliada Therapeutics is in Biotechnology
Answer: Aliada Therapeutics contact info: Phone number: +17********* Website: https://aliadatx.com
Answer: Biologics are transforming the treatment of numerous diseases, but many CNS diseases remain largely out of reach due to the challenge of crossing the blood-brain barrier and navigating the brains unique immune environment. Aliada is redefining what is possible in CNS drug development by building on a highly versatile and differentiated platform, with demonstrated proof of concept in NHPs. We are expanding this platform across a wide range of modalities, including monoclonal antibodies, enzymes, oligonucleotides, peptides, and other proteins. The delivery technology is customizable to CNS tissue and target localization via novel approaches to binding two distinct transport targets on the blood-brain barrier. In addition to the platform, Aliada is applying its novel technology to specific CNS target antibody binders and progressing these programs through preclinical evaluation.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month